FDA Approves New Medication for Severe, Persistent Asthma
Early November 2015, the FDA approved a new medication for the treatment of severe, persistent asthma called Nucala (mepolizumab). It is an injectable medication that is given once a month in the doctor’s office. Nucala is indicated for people 12-years-old and over who have difficult asthma that is not controlled by their usual medications.
Patient Testimonial: Angela of Atlanta
"Great practice full of friendly folks who really do work to help you feel better!”
Patient Testimonial: Allyson of Alpharetta
“I am seriously compelled to write a review for this practice because Dr. Schaffer is by far, the best doctor I have EVER seen. I have been going here for 3 years now, on a yearly basis, and I am always so happy after I leave. The service they provide is awesome."
New Research Study Reports Prevalence of Misdiagnosis for Children with Food Allergies
A recent study published in The Journal of Pediatrics reports that the use of a Food Allergy Blood test panel often results in misdiagnosis in children who are tested for food allergies.